Search
Descriptor English: Parasympathomimetics
Descriptor Spanish: Parasimpaticomiméticos
Descriptor parasimpaticomiméticos
Scope note: Fármacos que remedan los efectos de la actividad del sistema nervioso parasimpático. En esta clase se incluyen los fármacos que estimulan directamente a los receptores muscarínicos y aquellos que potencian la actividad colinérgica, generalmente al disminuir la eliminación de acetilcolina (INHIBIDORES DE LA COLINESTERASA); no se incluyen los fármacos que estimulan a las neuronas posganglionares simpáticas y parasimpáticas (ESTIMULANTES GANGLIONARES).
Descriptor Portuguese: Parassimpatomiméticos
Descriptor French: Parasympathomimétiques
Entry term(s): Agents, Parasympathomimetic
Drugs, Parasympathomimetic
Effect, Parasympathomimetic
Effects, Parasympathomimetic
Parasympathomimetic Agents
Parasympathomimetic Drugs
Parasympathomimetic Effect
Parasympathomimetic Effects
Tree number(s): D27.505.696.663.050.675
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D010277
Scope note: Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
Annotation: note entry term PARASYMPATHOMIMETIC EFFECT: use only for the parasympathomimetic effect of a chemical substance
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Related: Cholinesterase Inhibitors MeSH
Muscarinic Agonists MeSH
DeCS ID: 10466
Unique ID: D010277
NLM Classification: QV 122
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2011/06/24
Parasympathomimetics - Preferred
Concept UI M0015925
Scope note Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
Preferred term Parasympathomimetics
Entry term(s) Agents, Parasympathomimetic
Drugs, Parasympathomimetic
Parasympathomimetic Agents
Parasympathomimetic Drugs
Parasympathomimetic Effect - Related but not broader or narrower
Concept UI M0556218
Preferred term Parasympathomimetic Effect
Entry term(s) Effect, Parasympathomimetic
Effects, Parasympathomimetic
Parasympathomimetic Effects



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey